ADMA Biologics Inc. (ADMA) is set to join the S&P SmallCap 600 index, leading to a surge in its share price. This move, replacing Olympic Steel Inc., is effective before market open on September 23rd. The inclusion marks a positive step for ADMA and underscores its growing prominence in the healthcare sector.
Results for: ADMA Biologics
On CNBC’s ‘Mad Money Lightning Round’, Jim Cramer shared his insights on three companies: ADMA Biologics, MP Materials, and Delcath Systems. He expressed cautious optimism about ADMA Biologics, acknowledged the challenges facing MP Materials, and advised against investing in Delcath Systems.